跳至主要内容
临床试验/IRCT20191215045743N1
IRCT20191215045743N1已完成未知

The effectiveness of neurofeedback on the severity of gastrointestinal symptoms, depression, anxiety, stress and quality of life in patients with irritable bowel syndrome (IBS)

Esfahan University of Medical Sciences0 个研究点目标入组 45 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
45

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 45 years(—)
性别
All

入选标准

  • Having diagnostic criteria for IBS based on Rome III criteria , all three types of IBS included: C, D and M kind
  • age between 18 and 45 years
  • education: at least second level at middle school degree

排除标准

  • patients who refused to participate in study
  • positive Family history of colon cancer
  • WBC, parasites and blood in the stool
  • History of thyroid disorders and abnormal thyroid test,
  • Patients with unstable weight loss, anemia and eosinophilia, rectosigmoid and abnormal scoping
  • Having diagnostic Criteria of Severe psychiatric and neurological disorders based on psychiatrist diagnosis.
  • Having bloody stools

研究者

相似试验